Back to UBS Group AG UBS Group AG

GNPXGNPX

Showing 6 of 8 quarters

Position history for UBS Group AGUBS Group AG's holdings in Genprex, Inc.

No. UBS Group exited its GNPX (Genprex) position in Q4 2025. Its Q3 2025 13F listed 162,202 shares worth $27,412. UBS Group first reported GNPX in Q1 2024 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$20,402

Total Shares Change

-56,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$38.50
0
2025-Q3
Increased
162,202
+23.6%
$27,4120.0%$185.90
16
2025-Q2
Increased
131,239
+207.4%
$29,9230.0%$250.80
21
2025-Q1
Increased
42,686
+538.4%
$10,4580.0%$269.50
19
2024-Q4
Decreased
6,686
-88.1%
$5,6970.0%$937.20
0
2024-Q3
Increased
56,359
+618x
$20,4020.0%$398.20
21

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used